ROCKLAGE SCOTT M — SEC insider filings
SEC reporting owner CIK 1219014. 39 insider filings on record with FilingPulse; latest filed 2026-09-24.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2020-10-07 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 7,096,458 shares, $38,151,023 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 114 legs across 32 filings — 25,725,231 shares, $80,123,194 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: purchase of 5,206,074 shares @ $2.31 ($12,026,031) in Skye Bioscience, Inc., filed 2024-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Skye Bioscience, Inc. (SKYE) | 10% owner | 7 | 2 legs · 5,656,074 sh · $16,526,031 | 25 legs · 1,055,553 sh · $2,995,503 | — |
| Cabaletta Bio, Inc. (CABA) | 10% owner | 4 | — | 9 legs · 1,605,000 sh · $19,324,000 | — |
| Rallybio Corp (RLYB) | 10% owner | 5 | 1 leg · 615,384 sh · $7,999,992 | 7 legs · 560,000 sh · $6,735,500 | — |
| Homology Medicines, Inc. (FIXX) | 10% owner | 2 | — | 6 legs · 1,000,000 sh · $12,535,915 | — |
| IDEAYA Biosciences, Inc. (IDYA) | 10% owner | 1 | — | 3 legs · 800,000 sh · $10,928,000 | — |
| Entrada Therapeutics, Inc. (TRDA) | 10% owner | 6 | 1 leg · 250,000 sh · $5,000,000 | 13 legs · 531,285 sh · $4,068,043 | 10 |
| IMPEL NEUROPHARMA INC (IMPL) | 10% owner | 2 | 1 leg · 575,000 sh · $8,625,000 | — | 11 |
| Akouos, Inc. (AKUS) | 10% owner | 2 | — | 2 legs · 470,000 sh · $8,460,000 | 2 |
| Pear Therapeutics, Inc. (PEAR) | 10% owner | 6 | — | 33 legs · 18,431,771 sh · $5,712,873 | — |
| scPharmaceuticals Inc. (SCPH) | 10% owner | 3 | — | 15 legs · 1,096,622 sh · $4,935,860 | — |
+1 more issuer among the filings shown — every filing appears in the table below.
Insider filings — ROCKLAGE SCOTT M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-24 | 4 | Skye Bioscience, Inc. (SKYE) jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH | Sale (S): 27,612 @ $1.65 · Sale (S): 1,088 @ $1.65 · Sale (S): 114,851 @ $1.61 · Sale (S): 4,528 @ $1.61 | EDGAR |
| 2026-09-18 | 4 | Skye Bioscience, Inc. (SKYE) jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH | Sale (S): 32,607 @ $1.91 · Sale (S): 1,285 @ $1.91 | EDGAR |
| 2026-08-20 | 4 | Skye Bioscience, Inc. (SKYE) jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH | Sale (S): 45,090 @ $0.38 · Sale (S): 1,830 @ $0.38 · Sale (S): 253,080 @ $0.38 · Sale (S): 10,255 @ $0.35 · Sale (S): 409 @ $0.35 · Sale (S): 57,476 @ $0.35 · +3 more | EDGAR |
| 2026-08-10 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85 | EDGAR |
| 2026-08-03 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85 | EDGAR |
| 2025-11-18 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Sale (S): 200,000 @ $8.80 | EDGAR |
| 2025-08-22 | 4 | Skye Bioscience, Inc. (SKYE) jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH | Sale (S): 58,642 @ $3.57 · Sale (S): 2,314 @ $3.57 · Sale (S): 163,979 @ $3.42 · Sale (S): 6,470 @ $3.42 | EDGAR |
| 2025-07-11 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50 | EDGAR |
| 2025-07-01 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12 | EDGAR |
| 2024-09-13 | 4 | Skye Bioscience, Inc. (SKYE) jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH | Sale (S): 214,556 @ $6.60 · Sale (S): 36,504 @ $6.60 · Sale (S): 1,440 @ $6.60 · Sale (S): 11,758 @ $6.06 · Sale (S): 2,000 @ $6.06 · Sale (S): 79 @ $6.06 | EDGAR |
| 2024-03-15 | 4 | Skye Bioscience, Inc. (SKYE) jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH | Purchase (P): 450,000 @ $10 | EDGAR |
| 2024-02-02 | 4 | Skye Bioscience, Inc. (SKYE) jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH | Purchase (P): 5,206,074 @ $2.31 | EDGAR |
| 2023-04-12 | 4 | Pear Therapeutics, Inc. (PEAR) jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 12,836,489 @ $0.12 · Sale (S): 534,855 @ $0.12 · Sale (S): 3,172,769 @ $0.12 | EDGAR |
| 2023-03-09 | 4 | Rallybio Corp (RLYB) jointly with 5AM Partners V, LLC, Schwab Andrew J., 5AM Ventures V, L.P. | Sale (S): 100,000 @ $8.20 | EDGAR |
| 2022-12-02 | 4 | Akouos, Inc. (AKUS) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Code (U): 3,153,333 · Code (U): 982,453 | EDGAR |
| 2022-11-15 | 4 | Pear Therapeutics, Inc. (PEAR) jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 28,205 @ $3.19 · Sale (S): 1,175 @ $3.19 · Sale (S): 11,643 @ $2.79 · Sale (S): 485 @ $2.79 · Sale (S): 61,222 @ $2.52 · Sale (S): 2,551 @ $2.52 | EDGAR |
| 2022-11-02 | 4 | Pear Therapeutics, Inc. (PEAR) jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 40,477 @ $2.78 · Sale (S): 1,687 @ $2.78 · Sale (S): 1,408 @ $2.80 · Sale (S): 59 @ $2.80 · Sale (S): 10,155 @ $2.72 · Sale (S): 423 @ $2.72 | EDGAR |
| 2022-10-11 | 4 | scPharmaceuticals Inc. (SCPH) jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 30,457 @ $5.02 · Sale (S): 1,269 @ $5.02 · Sale (S): 5,808 @ $5.02 · Sale (S): 456,413 @ $4.09 · Sale (S): 19,017 @ $4.09 · Sale (S): 87,036 @ $4.09 | EDGAR |
| 2022-09-16 | 4 | Pear Therapeutics, Inc. (PEAR) jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 273,664 @ $1.94 · Sale (S): 11,403 @ $1.94 · Sale (S): 261,840 @ $1.81 · Sale (S): 10,910 @ $1.81 · Sale (S): 337 @ $1.75 · Sale (S): 14 @ $1.75 | EDGAR |
| 2022-09-08 | 4 | scPharmaceuticals Inc. (SCPH) jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 21,702 @ $5.52 · Sale (S): 904 @ $5.52 · Sale (S): 4,016 @ $5.52 · Sale (S): 163,034 @ $4.75 · Sale (S): 6,793 @ $4.75 · Sale (S): 30,173 @ $4.75 | EDGAR |
| 2022-09-08 | 4 | Pear Therapeutics, Inc. (PEAR) jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 298,714 @ $2.36 · Sale (S): 12,446 @ $2.36 · Sale (S): 148,337 @ $1.92 · Sale (S): 6,181 @ $1.92 · Sale (S): 292,149 @ $1.81 · Sale (S): 12,173 @ $1.81 | EDGAR |
| 2022-08-18 | 4 | Pear Therapeutics, Inc. (PEAR) jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 160,476 @ $1.78 · Sale (S): 6,686 @ $1.78 · Sale (S): 9,674 @ $1.71 · Sale (S): 403 @ $1.71 · Sale (S): 213,851 @ $1.55 · Sale (S): 8,910 @ $1.55 | EDGAR |
| 2022-06-07 | 4 | Rallybio Corp (RLYB) jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P. | Sale (S): 50,329 @ $12.50 · Sale (S): 99,671 @ $12.50 | EDGAR |
| 2022-05-25 | 4 | Rallybio Corp (RLYB) jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P. | Sale (S): 33,553 @ $13 · Sale (S): 66,447 @ $13 | EDGAR |
| 2022-04-13 | 4 | scPharmaceuticals Inc. (SCPH) jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 220,096 @ $5 · Sale (S): 9,171 @ $5 · Sale (S): 40,733 @ $5 | EDGAR |
| 2022-02-10 | 4 | Rallybio Corp (RLYB) jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P. | Sale (S): 70,461 @ $13.05 · Sale (S): 139,539 @ $13.05 | EDGAR |
| 2021-11-04 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Conversion (C): 318,616 · Conversion (C): 2,371,739 · Conversion (C): 564,217 · Conversion (C): 254,512 · Conversion (C): 318,140 · Purchase (P): 250,000 @ $20 · +5 more | EDGAR |
| 2021-11-03 | 4 | Cabaletta Bio, Inc. (CABA) jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J. | Sale (S): 258,456 @ $13 · Sale (S): 36,544 @ $13 | EDGAR |
| 2021-09-09 | 4 | Cabaletta Bio, Inc. (CABA) jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J. | Sale (S): 625,000 @ $9.70 | EDGAR |
| 2021-08-04 | 4 | Rallybio Corp (RLYB) jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P. | Purchase (P): 615,384 @ $13 | EDGAR |
| 2021-04-29 | 4 | IMPEL NEUROPHARMA INC (IMPL) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J., 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC | Conversion (C): 808,259 · Conversion (C): 540,265 · Conversion (C): 500,932 · Conversion (C): 358,878 · Conversion (C): 101,457 @ $13.50 · Purchase (P): 575,000 @ $15 · +5 more | EDGAR |
| 2021-04-26 | 4 | IMPEL NEUROPHARMA INC (IMPL) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J. | Other (J): 1,359,799.28 (derivative) @ $0 | EDGAR |
| 2021-01-12 | 4 | Cabaletta Bio, Inc. (CABA) jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J. | Sale (S): 264,589 @ $13 · Sale (S): 37,411 @ $13 · Sale (S): 74,470 @ $13 · Sale (S): 10,530 @ $13 | EDGAR |
| 2020-12-31 | 4 | Akouos, Inc. (AKUS) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J. | Sale (S): 358,352 @ $18 · Sale (S): 111,648 @ $18 | EDGAR |
| 2020-12-28 | 4 | Homology Medicines, Inc. (FIXX) jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 480,000 @ $12.82 · Sale (S): 20,000 @ $12.82 | EDGAR |
| 2020-12-16 | 4 | Homology Medicines, Inc. (FIXX) jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 151,138 @ $13.06 · Sale (S): 328,862 @ $11.88 · Sale (S): 6,297 @ $13.06 · Sale (S): 13,703 @ $11.88 | EDGAR |
| 2020-12-14 | 4 | Cabaletta Bio, Inc. (CABA) jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J. | Sale (S): 261,084 @ $14.75 · Sale (S): 36,916 @ $14.75 | EDGAR |
| 2020-11-13 | 4 | IDEAYA Biosciences, Inc. (IDYA) jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, DIEKMAN JOHN D, Schwab Andrew J. | Sale (S): 657,117 @ $13.66 · Sale (S): 27,379 @ $13.66 · Sale (S): 115,504 @ $13.66 | EDGAR |
| 2020-10-07 | 4 | Aprea Therapeutics, Inc. (APRE) jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, DIEKMAN JOHN D, Schwab Andrew J., PARMAR KUSH | Sale (S): 175,000 @ $25.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1219014 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs